摘要
目的:探讨胆汁反流性胃炎的发病原因及其药物治疗的疗效。方法:回顾性本院在2009年9月~2011年4月收治的80例胆汁反流性胃炎患者,患者分为铝碳酸镁组及奥美拉唑组+铝碳酸镁组进行治疗。结果:铝碳酸镁组的临床表现有效率为87.5%,胃镜疗效有效率为85.0%;奥美拉唑+铝碳酸镁组的临床表现有效率为95.0%,胃镜疗效有效率为95.0%。奥美拉唑+铝碳酸镁组显著优于铝碳酸镁组,差异有统计学意义;两组均无不良反应发生。结论:胆囊疾病和胃部手术为胆汁反流性胃炎的两大病因,奥美拉唑+铝碳酸镁可有效缓解胆汁反流性胃炎的临床症状,值得临床推广。
Objective:To investigate the pathogen and efficacy of bile reflux gastritis.Methods:80 cases of bile reflux gastritis patients from September 2009 to April 2011 in our hospital were retrospectively analyzed who were divided into hydrotalcite and omeprazole group and omeprazole group.Results:The efficacy in symptoms and gastroscope of omeprazole group were 87.5% and 85.0% which were obviously lower than that of hydrotalcite and omeprazole group which were both 95.0%(P0.05).The effects of hydrotalcite and omeprazole group were significantly better than the omeprazole group,difference was statistically significant;There were no adverse reactions in two groups.Conclusion:Gallbladder disease and gastreetomy are the main pathogens.And the hydrotalcite and omeprazole can effectively relieve the clinical symptoms of bile reflux gastritis which deserves clinical promotion.
出处
《中国当代医药》
2011年第31期54-55,共2页
China Modern Medicine
关键词
胆汁反流性胃炎
病因
药物
治疗
Bile reflux gastritis
Pathogen
Medical
Therapy